Your browser doesn't support javascript.
loading
Chemotherapy following radium-223 dichloride treatment in ALSYMPCA.
Sartor, Oliver; Hoskin, Peter; Coleman, Robert E; Nilsson, Sten; Vogelzang, Nicholas J; Petrenciuc, Oana; Staudacher, Karin; Thuresson, Marcus; Parker, Christopher.
Afiliación
  • Sartor O; Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana.
  • Hoskin P; Department of Urology, Tulane Cancer Center, New Orleans, Louisiana.
  • Coleman RE; Marie Curie Research Wing for Oncology, Mount Vernon Hospital Cancer Centre, Middlesex, United Kingdom.
  • Nilsson S; Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom.
  • Vogelzang NJ; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Petrenciuc O; Department of Medical Oncology, University of Nevada School of Medicine and Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada.
  • Staudacher K; Department of Global Clinical Development, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey.
  • Thuresson M; Department of Study Management Europe, Bayer AS (formerly Algeta ASA), Oslo, Norway.
  • Parker C; Department of Biostatistics, Statisticon AB, Uppsala, Sweden.
Prostate ; 76(10): 905-16, 2016 07.
Article en En | MEDLINE | ID: mdl-27004570

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radio (Elemento) / Neoplasias de la Próstata Resistentes a la Castración / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radio (Elemento) / Neoplasias de la Próstata Resistentes a la Castración / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2016 Tipo del documento: Article